It’s one of the market’s biggest missed opportunities. Every day, millions of U.S. investors looking for more income are missing out. That’s because the vast majority of the world’s highest-yields aren’t found in the United States. As the Chief Strategist of High-Yield International, my job is to scour the globe for the world’s highest yielding investments and tell my readers about them each month. At last count, my research shows that over 79% of the world’s highest-yielding stocks are based in international markets. If you’re like most people, then you’ve probably… Read More

It’s one of the market’s biggest missed opportunities. Every day, millions of U.S. investors looking for more income are missing out. That’s because the vast majority of the world’s highest-yields aren’t found in the United States. As the Chief Strategist of High-Yield International, my job is to scour the globe for the world’s highest yielding investments and tell my readers about them each month. At last count, my research shows that over 79% of the world’s highest-yielding stocks are based in international markets. If you’re like most people, then you’ve probably never taken advantage of foreign stocks. #-ad_banner-#That’s a shame, because the average stock in the United Kingdom yields 3.8%, Australia’s average yield is 4.5% and New Zealand pays 4.3%. By contrast, U.S. stocks yield less than 2%, on average. Most U.S. investors dismiss the idea of investing abroad. They tend to think other countries are “riskier” than the United States. But that’s not always the case. Especially with one special country I’ll tell you about in a moment, where average yields are double those found in the United… Read More

Turns in investor sentiment can make you double- and even triple-digit gains if you are early enough. The risk is being too early. The wait can be excruciating — and costly.  Just ask gold bugs.  Historic money printing by the largest central banks should have stoked inflation, deflating currencies and sending gold prices higher. And the 30% plunge in gold prices in 2013 should have led to production cuts and greater demand. Yet, gold prices have gone nowhere since the beginning of 2014. The wait for gold to rebound has led to big losses for many. SPDR Gold… Read More

Turns in investor sentiment can make you double- and even triple-digit gains if you are early enough. The risk is being too early. The wait can be excruciating — and costly.  Just ask gold bugs.  Historic money printing by the largest central banks should have stoked inflation, deflating currencies and sending gold prices higher. And the 30% plunge in gold prices in 2013 should have led to production cuts and greater demand. Yet, gold prices have gone nowhere since the beginning of 2014. The wait for gold to rebound has led to big losses for many. SPDR Gold Shares (NYSE: GLD) is nearly 11% off its 52-week highs, and the Market Vectors Gold Miners ETF (NYSE: GDX) is down 29% from its highs of the past year. #-ad_banner-# But for the leader in the space, this year may be a turning point. Better still, we can make double-digit returns even if the stock goes nowhere. Where are the Gold Bugs Now? Relative to the fervor for gold over the past several years, it seems you hardly hear pundits talk of the… Read More

After many years of neglect, the pipeline for new antibiotic drugs is finally beginning to ramp up again. The catalyst: the rise of “superbugs,” which are bacteria that have developed resistance to some or all of the currently available antibiotics. Infections with such bacteria can be extremely difficult or even impossible to treat, and they’re often far more severe than those caused by non-resistant organisms. In the latest government budget proposal, which allocates $1.2 billion to combatting antibiotic resistance, the Obama administration estimated that superbugs now cause two million illnesses and 23,000 deaths annually in the United States. The failure… Read More

After many years of neglect, the pipeline for new antibiotic drugs is finally beginning to ramp up again. The catalyst: the rise of “superbugs,” which are bacteria that have developed resistance to some or all of the currently available antibiotics. Infections with such bacteria can be extremely difficult or even impossible to treat, and they’re often far more severe than those caused by non-resistant organisms. In the latest government budget proposal, which allocates $1.2 billion to combatting antibiotic resistance, the Obama administration estimated that superbugs now cause two million illnesses and 23,000 deaths annually in the United States. The failure to address antibiotic resistance (by creating new antibiotics, among other measures) could lead to 300 million premature deaths worldwide and shear up to $100 trillion off of the global economy over the next 35 years, notes economist Jim O’Neill. #-ad_banner-#Despite the gravity of the issue, large pharmaceutical companies devote virtually no resources to antibiotic development and haven’t for years. “Big Pharma” largely quit the antibiotics business back in the 1990s, deterred mainly by high R&D costs and low perceived profit potential. To help stimulate new advances, the federal government passed the Generating Antibiotic Incentives Now (GAIN) Act. The 2012 legislation… Read More

Average Gains of 144% — Is it Possible? One of the top trading experts in the world has created a unique, two-part options strategy with average annualized gains that seem too good to be true: 89% in 2012… 144% in 2013… 211% in 2014. I can’t guarantee you’ll have the same kind of success. But if history is any guide, it could help you make annualized gains of 220%… 508%… even 2,201% — which is what it has delivered over the past few weeks. We’ve put together a… Read More

Average Gains of 144% — Is it Possible? One of the top trading experts in the world has created a unique, two-part options strategy with average annualized gains that seem too good to be true: 89% in 2012… 144% in 2013… 211% in 2014. I can’t guarantee you’ll have the same kind of success. But if history is any guide, it could help you make annualized gains of 220%… 508%… even 2,201% — which is what it has delivered over the past few weeks. We’ve put together a free webpage revealing the details behind this strategy. Click here to go there now. Sincerely, Frank Bermea Publisher, Profitable Trading P.S. This expert just revealed his latest trade. He expects it to deliver 106% — but only if you take advantage immediately. Click here to get all the details. All major U.S. indices except for the blue-chip Dow Jones Industrial Average closed higher last week, led by the tech-heavy Nasdaq 100 and small-cap Russell 2000,… Read More

The initial public offering class of 2014 was surely an elite group. 275 companies raised a combined $85 billion, the highest amount since 2000. High-profile companies such as Alibaba Group Holding Ltd. (NYSE: BABA) led the pack, scoring a sharp 38% first-day gain. Yet other notable IPOs that managed to generate impressive first-day gains eventually fell out of favor. Roughly six months ago, I cautioned against chasing shares of LendingClub Corp. (NYSE: LC), after shares had surged roughly 60% from the IPO price. “Investors may want to consider waiting for a better entry point as enthusiasm wanes,” I noted then. Read More

The initial public offering class of 2014 was surely an elite group. 275 companies raised a combined $85 billion, the highest amount since 2000. High-profile companies such as Alibaba Group Holding Ltd. (NYSE: BABA) led the pack, scoring a sharp 38% first-day gain. Yet other notable IPOs that managed to generate impressive first-day gains eventually fell out of favor. Roughly six months ago, I cautioned against chasing shares of LendingClub Corp. (NYSE: LC), after shares had surged roughly 60% from the IPO price. “Investors may want to consider waiting for a better entry point as enthusiasm wanes,” I noted then. Still, I have been keeping a close eye on the shares, as this banking game-changer held vast long-term potential. Although the stock has fallen nearly 40% from its post-IPO high, several deals subsequently signed with powerhouses like Google, Inc. (Nasdaq: GOOG) and Alibaba should boost growth over the next several years. Revenue is already expected to grow 85% this year and the company’s industry — peer-to-peer lending — is projected to grow 40% a year for the next decade. The Future Of Banking Is Online Peer lending has gone from being an internet curiosity to… Read More

It’s an old investing axiom that that many of the companies with the highest growth potential are private and thus out of reach for investors of the public markets. Venture Capital (VC) firms are the ones making investments in early stage growth companies, but it usually takes big bucks to get in on the action. GSV Capital Corp. (Nasdaq: GSVC) is a publicly traded VC that allows regular investors to invest in hyper-growth companies. Better yet, the firm’s stock trades at a discount and has several potential catalysts that could send shares higher. In early-stage investing, there are going to… Read More

It’s an old investing axiom that that many of the companies with the highest growth potential are private and thus out of reach for investors of the public markets. Venture Capital (VC) firms are the ones making investments in early stage growth companies, but it usually takes big bucks to get in on the action. GSV Capital Corp. (Nasdaq: GSVC) is a publicly traded VC that allows regular investors to invest in hyper-growth companies. Better yet, the firm’s stock trades at a discount and has several potential catalysts that could send shares higher. In early-stage investing, there are going to be hits and misses, that’s just the nature of the beast. However, GSV has shown it has a knack for picking winners. It invested in Facebook, Inc. (Nasdaq: FB) and Twitter, Inc. (NYSE: TWTR) prior to their initial public offerings (IPOs). This is a company that’s done very well for investors, steadily growing its net asset value per share over the last three years. Despite the company steadily growing assets per share, the stock price hasn’t followed suit. Despite trading for a slight premium to net asset value during the first few years of its existence, it now… Read More

While most investors tend to focus on large and stable companies with decent growth prospects, some investors only seek out undiscovered stocks that have the potential to double, triple or even quadruple your investment. The companies underpinning such potential gains are often known as “game-changers” because they possess a new technology that can completely alter existing industry dynamics. My colleague, Andy Obermueller, who pen’s StreetAuthority’s Game-Changing Stocks, has shown an uncanny knack for revealing such companies over the years. Yet as you seek out such companies, don’t just focus on their income statements. Instead, keep a close eye on the… Read More

While most investors tend to focus on large and stable companies with decent growth prospects, some investors only seek out undiscovered stocks that have the potential to double, triple or even quadruple your investment. The companies underpinning such potential gains are often known as “game-changers” because they possess a new technology that can completely alter existing industry dynamics. My colleague, Andy Obermueller, who pen’s StreetAuthority’s Game-Changing Stocks, has shown an uncanny knack for revealing such companies over the years. Yet as you seek out such companies, don’t just focus on their income statements. Instead, keep a close eye on the company’s levels of cash. The best time to own such stocks is often right after the balance sheet has been bolstered. Let me give an example. Back in September 2013, I saw huge potential upside for Novavax, Inc. (Nasdaq: NVAX), which had been developing a range of treatments for various viruses. Considering that this stock had moved sideways in prior years made it seem foolish to predict robust imminent upside. But Novavax did something that instantly changed sentiment. It raised a lot of money.  Novavax typically finished every year with $30-to-$40 million in the bank. Investors rightly understood… Read More

Over the last decade, we’ve published thousands of in-depth research reports. Everything from high dividend payers, game-changing innovations, top stocks in emerging markets — you name it, we’ve told you how to profit from it. But the research I’m going to tell you about today stands head and shoulders above everything else we’ve ever done. In fact, it ranks as our single most popular report of all time. Each year, we update the report with our team’s most recent findings. And frankly, I think what we’ve come up… Read More

Over the last decade, we’ve published thousands of in-depth research reports. Everything from high dividend payers, game-changing innovations, top stocks in emerging markets — you name it, we’ve told you how to profit from it. But the research I’m going to tell you about today stands head and shoulders above everything else we’ve ever done. In fact, it ranks as our single most popular report of all time. Each year, we update the report with our team’s most recent findings. And frankly, I think what we’ve come up with this year represents a major breakthrough. We call it: “The 10 Stocks To Own For The Rest Of Your Life” #-ad_banner-#You’ve probably heard us talk about the idea of “Forever Stocks” before. Simply put, these are solid companies that we think you can feel confident buying and holding onto for years, even decades. And we believe they will continue rewarding investors for years on end… crushing the market over the long run. They’re the kinds of stocks you’d ideally want to own forever. Owning solid, stable companies… Read More

One of my favorite things to see in a long candidate is a pattern of beating Wall Street’s earnings estimates. After all, if a stock beats the Street consistently, it is doing many things right.   An earnings beat will often cause a stock’s price to pop, and when that stock also sports a superb long-term chart, I know I have found a winner. The Bank of New York Mellon (NYSE: BK) fits this description to a T. In the company’s past 18 quarterly earnings reports, going back to the end of 2010, it has only missed Zacks’ consensus estimate… Read More

One of my favorite things to see in a long candidate is a pattern of beating Wall Street’s earnings estimates. After all, if a stock beats the Street consistently, it is doing many things right.   An earnings beat will often cause a stock’s price to pop, and when that stock also sports a superb long-term chart, I know I have found a winner. The Bank of New York Mellon (NYSE: BK) fits this description to a T. In the company’s past 18 quarterly earnings reports, going back to the end of 2010, it has only missed Zacks’ consensus estimate three times. And it has beaten estimates more than 72% of the time. In the most recently reported quarter, announced in April, Bank of New York Mellon exceeded estimates by nearly 14%. #-ad_banner-# The financial institution has a storied history. The Bank of New York was founded in 1784 by the future first U.S. Secretary of the Treasury, Alexander Hamilton, whose portrait adorns the $10 bill. It grew steadily over the centuries and merged with Mellon Financial in 2007.   The Bank of… Read More